The Alzheimer’s Disease Drugs Market is experiencing a pivotal transformation. Following decades marked by high attrition rates and late-stage clinical failures, the period between 2023 and 2025 witnessed the first widely recognized successes in disease-modifying therapies (DMTs). These breakthroughs are reshaping both clinical practice and commercial strategies. Coupled with aging...